Breast cancer is heterogeneous disease comprising phenotypically diverse tumours categorised into molecular subtypes based on the overexpression of receptors for the hormones oestrogen (ER) or progesterone (PR), or for the human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.